Novogene Investment establishes a genetic technology company
According to the Qichacha APP, recently, Beijing Novogene Bioinformatics Technology Co., Ltd. was established, with Yu Yang as the legal representative and a registered capital of 30 million yuan. The business scope includes: natural science research and experimental development; medical research and experimental development; biotechnology product technology research and development; sales of electronic products, etc. Qichacha's equity penetration shows that the company is wholly owned by Novogene
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments